@article{de83aeae94354d228f4dfd8abd40288a,
title = "Making a case “for” focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials",
abstract = "Focal therapy is growing as an alternative management options for men with clinically localized prostate cancer. Parallel to the increasing popularity of active surveillance (AS) as a treatment for low-risk disease, there has been an increased interest towards providing focal therapy for patients with intermediate-risk disease. Focal therapy can act as a logical “middle ground” in patients who seek treatment while minimizing potential side effects of definitive whole-gland treatment. The aim of the current review is to define the rationale of focal therapy in patients with intermediate-risk prostate cancer and highlight the importance of patient selection in focal therapy candidacy.",
keywords = "Focal therapy, MRI, prostate cancer",
author = "Wang, {Alex Z.} and Lebastchi, {Amir H.} and O{\textquoteright}Connor, {Luke P.} and Michael Ahdoot and Sherif Mehralivand and Nitin Yerram and Taneja, {Samir S.} and George, {Arvin K.} and Rafael Sanchez-Salas and Ward, {John F.} and Pilar Laguna and {de la Rosette}, Jean and Pinto, {Peter A.}",
note = "Funding Information: This research was made possible through the NIH Medical Research Scholars Program, a public private partnership supported jointly by the NIH and contributions to the Foundation for the NIH from the Doris Duke Charitable Foundation, Genentech, the American Association for Dental Research, the Colgate-Palmolive Company, and other private donors. Publisher Copyright: {\textcopyright} 2021, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.",
year = "2021",
month = mar,
doi = "10.1007/s00345-020-03525-0",
language = "English (US)",
volume = "39",
pages = "729--739",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "3",
}